Monlunabant in adults with obesity and metabolic syndrome: Open‐label extension of a phase 2a trial
Diabetes, Obesity and Metabolism · 2026-05 · 28 (5) · 4366-4371
DOI: 10.1111/dom.70580 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 24.03.2026. Verfasst von Filip K Knop und 10 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk, Søborg, Denmark. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Inversago Pharma Inc. (a Novo Nordisk company).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Novo Nordisk, Søborg, Denmark.
- Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH, Bethesda, Maryland, USA.
- Internal Medicine Department D and Obesity Clinic, Hasharon Hospital-Rabin Medical Center, Petach-Tikva, Gray Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Laboratoire de recherche et d'innovation en médecine de première ligne (ARIMED), Groupe de médecine de famille universitaire de Saint-Charles-Borromée, CISSS Lanaudière, Saint-Charles-Borromée, Québec, Canada.
- VITAM Research Centre for Sustainable Health, Québec City, Québec, Canada.
- Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Université Laval, Québec City, Québec, Canada.
ORCID-Profile: Filip K Knop, George Kunos, Dror Dicker, Jean-Sebastien Paquette, Louis Aronne, Oscar Birkhan, Ofir Frenkel, Thomas Holst-Hansen, Karine Lalonde, Glenn Crater
Förderung
- Inversago Pharma Inc. (a Novo Nordisk company)
Zitieren
APA
Knop, F. K., Kunos, G., Dicker, D., Paquette, J. S., Aronne, L., Birkhan, O., Frenkel, O., Holst-Hansen, T., Lalonde, K., Crater, G., & trial investigators (2026). Monlunabant in adults with obesity and metabolic syndrome: Open‐label extension of a phase 2a trial. Diabetes, Obesity and Metabolism, 28(5), 4366-4371. https://doi.org/10.1111/dom.70580
Vancouver
Knop FK, Kunos G, Dicker D, Paquette JS, Aronne L, Birkhan O, et al. Monlunabant in adults with obesity and metabolic syndrome: Open‐label extension of a phase 2a trial. Diabetes, Obesity and Metabolism. 2026;28(5):4366-4371. doi:10.1111/dom.70580
BibTeX
@article{Knop2026,
author = {Knop, Filip K and Kunos, George and Dicker, Dror and Paquette, Jean-Sebastien and Aronne, Louis and Birkhan, Oscar and Frenkel, Ofir and Holst-Hansen, Thomas and Lalonde, Karine and Crater, Glenn and trial investigators, trial investigators},
title = {Monlunabant in adults with obesity and metabolic syndrome: Open‐label extension of a phase 2a trial},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {5},
pages = {4366--4371},
doi = {10.1111/dom.70580}
}
EUVIMED